Literature DB >> 28983729

Increased CaSR and TRPC6 pulmonary vascular expression in the nitrofen-induced model of congenital diaphragmatic hernia.

Hiroki Nakamura1, Julia Zimmer2, Tristan Lim3, Prem Puri4,5.   

Abstract

AIMS AND
OBJECTIVES: The high morbidity and mortality rates in congenital diaphragmatic hernia (CDH) are attributed primarily to severe lung hypoplasia and/or persistent pulmonary hypertension (PPH). PPH in CDH is characterized by abnormal vascular remodeling with thickening of medial and adventitial layers and extension of smooth muscle into previously nonmuscularized arteries. Excessive proliferation of pulmonary arterial smooth muscle cells (PASMC) is an important contributor to the concentric pulmonary arterial remodeling. An increase in cytosolic-free Ca2+ concentration in PASMC is a major trigger for pulmonary vasoconstriction and a key stimulus for PASMC proliferation and migration. Calcium-sensing receptor (CaSR), a member of the G-protein coupled receptor family, is activated by cations (e.g., Ca2+, Mg2+) and polyamines. Under normal physiological conditions, the expression levels of CaSR in the pulmonary vasculature are very low. Canonical transient receptor potential channels (TRPCs) constitute a series of nonselective cation channels with variable degree of Ca2+ selectivity. TRPC6 has been reported to play a crucial role in the regulation of neo-muscularization, vasoreactivity, and vasomotor tone in the pulmonary vasculature. We hypothesized that CaSR and TRPC6 expression is upregulated in the pulmonary vasculature of nitrofen-induced CDH rats.
MATERIALS AND METHODS: Following ethical approval (REC1103), time-pregnant Sprague Dawley rats received nitrofen or vehicle on gestational day (D) 9. D21 fetuses were divided into CDH and control (n = 12). Quantitative real-time polymerase chain reaction (QRT-PCR), western blotting, and confocal-immunofluorescence microscopy were performed to detect lung gene and protein expression of CaSR and TRPC6.
RESULTS: QRT-PCR and western blot analysis revealed that CaSR and TPRC6 expression was significantly increased in the CDH group compared to controls (p < 0.05). Confocal-immunofluorescence microscopy revealed that CaSR and TRPC6 lung expression was markedly increased in CDH group compared to controls.
CONCLUSION: Increased CaSR and TRPC6 expression in CDH lung suggests that CaSR interacting with TRPC6 may contribute to abnormal vascular remodeling resulting in pulmonary vasoconstriction and development of PPH.

Entities:  

Keywords:  CaSR; Congenital diaphragmatic hernia; Pulmonary hypertension; TRPC

Mesh:

Substances:

Year:  2017        PMID: 28983729     DOI: 10.1007/s00383-017-4191-3

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  10 in total

1.  Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.

Authors:  Aya Yamamura; Qiang Guo; Hisao Yamamura; Adriana M Zimnicka; Nicole M Pohl; Kimberly A Smith; Ruby A Fernandez; Amy Zeifman; Ayako Makino; Hui Dong; Jason X-J Yuan
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

2.  Structural immaturity of the heart in congenital diaphragmatic hernia in rats.

Authors:  N Guarino; H Shima; P Puri
Journal:  J Pediatr Surg       Date:  2001-05       Impact factor: 2.545

Review 3.  New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.

Authors:  Christophe Guignabert; Ly Tu; Barbara Girerd; Nicolas Ricard; Alice Huertas; David Montani; Marc Humbert
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

Review 4.  New mechanisms of pulmonary arterial hypertension: role of Ca²⁺ signaling.

Authors:  Frank K Kuhr; Kimberly A Smith; Michael Y Song; Irena Levitan; Jason X-J Yuan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-13       Impact factor: 4.733

Review 5.  Congenital diaphragmatic hernia.

Authors:  Richard Keijzer; Prem Puri
Journal:  Semin Pediatr Surg       Date:  2010-08       Impact factor: 2.754

6.  Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension.

Authors:  Haiyang Tang; Aya Yamamura; Hisao Yamamura; Shanshan Song; Dustin R Fraidenburg; Jiwang Chen; Yali Gu; Nicole M Pohl; Tong Zhou; Laura Jiménez-Pérez; Ramon J Ayon; Ankit A Desai; David Goltzman; Franz Rischard; Zain Khalpey; Stephan M Black; Joe G N Garcia; Ayako Makino; Jason X J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-03-11       Impact factor: 5.464

Review 7.  Pulmonary vascular development goes awry in congenital lung abnormalities.

Authors:  Heleen Kool; Daphne Mous; Dick Tibboel; Annelies de Klein; Robbert J Rottier
Journal:  Birth Defects Res C Embryo Today       Date:  2014-11-26

8.  Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension.

Authors:  Ying Yu; Ivana Fantozzi; Carmelle V Remillard; Judd W Landsberg; Naomi Kunichika; Oleksandr Platoshyn; Donna D Tigno; Patricia A Thistlethwaite; Lewis J Rubin; Jason X-J Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-09       Impact factor: 11.205

9.  TRPC6 is the endothelial calcium channel that regulates leukocyte transendothelial migration during the inflammatory response.

Authors:  Evan W Weber; Fei Han; Mohammad Tauseef; Lutz Birnbaumer; Dolly Mehta; William A Muller
Journal:  J Exp Med       Date:  2015-09-21       Impact factor: 14.307

Review 10.  Calcium-Sensing Receptor Regulates Cytosolic [Ca 2+ ] and Plays a Major Role in the Development of Pulmonary Hypertension.

Authors:  Kimberly A Smith; Ramon J Ayon; Haiyang Tang; Ayako Makino; Jason X-J Yuan
Journal:  Front Physiol       Date:  2016-11-04       Impact factor: 4.566

  10 in total
  1 in total

Review 1.  Calcium-sensing receptor in the development and treatment of pulmonary hypertension.

Authors:  Ming-Yuan Zhou; Lin Cheng; Lei Chen; Ying-Jian Gu; Yun Wang
Journal:  Mol Biol Rep       Date:  2021-01-04       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.